Whittier Trust’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,839
Closed -$20K 1797
2022
Q1
$20K Hold
2,839
﹤0.01% 1207
2021
Q4
$52K Hold
2,839
﹤0.01% 973
2021
Q3
$56K Hold
2,839
﹤0.01% 908
2021
Q2
$127K Hold
2,839
﹤0.01% 744
2021
Q1
$143K Buy
+2,839
New +$194K ﹤0.01% 705

Other funds holding CELL

Whittier Trust's CELL Position: Q2 2022 in Review

Whittier Trust sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2022, closing a stake of 2,839 shares — an estimated $20K sold.

Whittier Trust first reported a position in CELL in Q1 2021 and held it in 5 quarters. The position peaked at $143K in Q1 2021. 123 funds tracked by Wall St. Rank hold CELL as of Q2 2022.

  • Whittier Trust reported no remaining PhenomeX Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Whittier Trust sold 2,839 PhenomeX Inc. Common Stock shares in Q2 2022, an estimated $20K.
  • Whittier Trust first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • Whittier Trust's PhenomeX Inc. Common Stock position peaked at $143K in Q1 2021.
  • 123 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2022.

Based on Whittier Trust's 13F filing for Q2 2022, filed 28 Jul 2022.